Introduction Lung cancer risk prediction models have the potential to make programs more
affordable; however, the economic evidence is limited. Methods Participants in the National …

Background Cancer is a major public health issue and represents a significant economic
burden to health care systems worldwide. The objective of this analysis was to estimate phase-…

Background The first year after cancer diagnosis is a period of intensive treatment and high
cost. We sought to estimate costs for the 21 most common cancers in Ontario in the 3-month …

Background: An important challenge with the application of next-generation sequencing
technology is the possibility of uncovering incidental genomic findings. A paucity of evidence on …

Context Despite being commonplace in health care systems, little research has described
home care nursing's effectiveness to reduce acute care use at the end of life. Objectives To …

Purpose: To develop data-driven and achievable benchmark rates for end-of-life quality
indicators using administrative data from four provinces in Canada. Methods: Indicators of end-of…

Background Women with mutations in BRCA1 or BRCA2 are at high risk of developing
breast cancer and, in British Columbia, Canada, are offered screening with both magnetic …

Methods: Using linked cancer registry and administrative data, and standardized costing
methodology and analyses, we estimated costs for 21 cancer sites by phase of care to …

Prostate‐specific antigen (PSA) screening for prostate cancer may reduce mortality, but it
incurs considerable risk of over diagnosis and potential harm to quality of life. Our objective …

Background Cancer incidence and treatment-related costs are rising in Canada. We estimated
health care use and costs in the first year after diagnosis for patients with 7 common types …